Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Senn

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|November 30, 2002
Power is indeed irrelevant in interpreting completed studiesStephen J Senn
BMJ (Clinical Research Ed.)|June 28, 2003
Ethics of clinical trials from bayesian perspective: society's role is importantStephen J Senn
BMJ (Clinical Research Ed.)|May 8, 2004
Turning a blind eye: authors have blinkered view of blindingStephen J Senn
BMJ (Clinical Research Ed.)|February 4, 2006
JAMA's policy does not go far enoughStephen J Senn
BMJ (Clinical Research Ed.)|April 19, 2003
Competing interests. Consent was not obtainedStephen J Senn
BMC Medical Research Methodology|February 17, 2009
Overstating the evidence: double counting in meta-analysis and related problemsStephen J Senn
JAMA|March 2, 2019
Treatment Effects in Multicenter Randomized Clinical TrialsStephen J Senn, Roger J Lewis
Statistical Methods in Medical Research|October 11, 2019
Clustered allocation as a way of understanding historical controls: Components of variation and regulatory considerationsOlivier Collignon, Anna Schritz, Stephen J Senn, et al.
The Oncologist|February 1, 2021
Implementing Historical Controls in Oncology TrialsOlivier Collignon, Anna Schritz, Riccardo Spezia, et al.
Statistics in Medicine|February 5, 2026
An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical TrialsErik W van Zwet, Frank E Harrell, Stephen J Senn
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|November 30, 2002
Power is indeed irrelevant in interpreting completed studiesStephen J Senn
BMJ (Clinical Research Ed.)|June 28, 2003
Ethics of clinical trials from bayesian perspective: society's role is importantStephen J Senn
BMJ (Clinical Research Ed.)|May 8, 2004
Turning a blind eye: authors have blinkered view of blindingStephen J Senn
BMJ (Clinical Research Ed.)|February 4, 2006
JAMA's policy does not go far enoughStephen J Senn
BMJ (Clinical Research Ed.)|April 19, 2003
Competing interests. Consent was not obtainedStephen J Senn
BMC Medical Research Methodology|February 17, 2009
Overstating the evidence: double counting in meta-analysis and related problemsStephen J Senn
JAMA|March 2, 2019
Treatment Effects in Multicenter Randomized Clinical TrialsStephen J Senn, Roger J Lewis
Statistical Methods in Medical Research|October 11, 2019
Clustered allocation as a way of understanding historical controls: Components of variation and regulatory considerationsOlivier Collignon, Anna Schritz, Stephen J Senn, et al.
The Oncologist|February 1, 2021
Implementing Historical Controls in Oncology TrialsOlivier Collignon, Anna Schritz, Riccardo Spezia, et al.
Statistics in Medicine|February 5, 2026
An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical TrialsErik W van Zwet, Frank E Harrell, Stephen J Senn
Pageof 2